The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting

© 2021. The Author(s)..

Programmed ribosomal frameshifting (PRF) is a fundamental gene expression event in many viruses, including SARS-CoV-2. It allows production of essential viral, structural and replicative enzymes that are encoded in an alternative reading frame. Despite the importance of PRF for the viral life cycle, it is still largely unknown how and to what extent cellular factors alter mechanical properties of frameshift elements and thereby impact virulence. This prompted us to comprehensively dissect the interplay between the SARS-CoV-2 frameshift element and the host proteome. We reveal that the short isoform of the zinc-finger antiviral protein (ZAP-S) is a direct regulator of PRF in SARS-CoV-2 infected cells. ZAP-S overexpression strongly impairs frameshifting and inhibits viral replication. Using in vitro ensemble and single-molecule techniques, we further demonstrate that ZAP-S directly interacts with the SARS-CoV-2 RNA and interferes with the folding of the frameshift RNA element. Together, these data identify ZAP-S as a host-encoded inhibitor of SARS-CoV-2 frameshifting and expand our understanding of RNA-based gene regulation.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:12

Enthalten in:

Nature communications - 12(2021), 1 vom: 10. Dez., Seite 7193

Sprache:

Englisch

Beteiligte Personen:

Zimmer, Matthias M [VerfasserIn]
Kibe, Anuja [VerfasserIn]
Rand, Ulfert [VerfasserIn]
Pekarek, Lukas [VerfasserIn]
Ye, Liqing [VerfasserIn]
Buck, Stefan [VerfasserIn]
Smyth, Redmond P [VerfasserIn]
Cicin-Sain, Luka [VerfasserIn]
Caliskan, Neva [VerfasserIn]

Links:

Volltext

Themen:

Journal Article
Protein Isoforms
Proteome
RNA, Viral
RNA-Binding Proteins
Repressor Proteins
Research Support, Non-U.S. Gov't
YLPM1 protein, human

Anmerkungen:

Date Completed 21.12.2021

Date Revised 04.04.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41467-021-27431-0

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM334301262